Prices for key medicines may skyrocket
Trump's introduction of new tariffs could lead to higher prices for pharmaceuticals from major manufacturers in immuno-oncology, anti-tumor therapy, diabetes treatment, and cosmetology segments.
Pharmaceutical companies are calling on US and EU authorities to exclude medical goods from the trade conflict, fearing price increases and supply disruptions. The tariffs are expected to affect European-manufactured drugs such as Novo Nordisk's Wegovy, Merck's Keytruda, and AbbVie's Botox.
According to industry insiders, pharmaceutical companies are negotiating with Donald Trump's administration and Brussels, warning that tariff wars will hit patients, increase treatment costs, and threaten the availability of vital medicines.
Some manufacturers are ready to increase production in the US, demanding tax breaks and easing of regulation. Experts warn of the billions in investments and many years of project implementation, as well as the risk of the situation worsening due to the disruption of supply chains between the US and Europe.
Although the tariff dispute between the US and the EU does not directly affect Central Asia, its consequences can be felt in the region through price increases, possible supply disruptions, and changes in logistics routes.
According to industry insiders, pharmaceutical companies are negotiating with Donald Trump's administration and Brussels, warning that tariff wars will hit patients, increase treatment costs, and threaten the availability of vital medicines.
Some manufacturers are ready to increase production in the US, demanding tax breaks and easing of regulation. Experts warn of the billions in investments and many years of project implementation, as well as the risk of the situation worsening due to the disruption of supply chains between the US and Europe.
Although the tariff dispute between the US and the EU does not directly affect Central Asia, its consequences can be felt in the region through price increases, possible supply disruptions, and changes in logistics routes.
Powered by Froala Editor